Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 730 HALO shares, $78.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 730 | $78.2K |
| Sep 17, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 3,100 | $329.0K |
| Jun 22, 2026 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 45,000 | n/a |
| May 7, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 3,796 | n/a |
| Jun 25, 2025 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 45,000 | n/a |
| May 2, 2025 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 4,165 | n/a |
| Aug 14, 2024 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 10,000 | $557.2K |
| Jun 17, 2024 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 45,000 | n/a |
| Jun 13, 2024 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 10,000 | $500.1K |
| Apr 29, 2024 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 6,501 | n/a |